Table 2.
Patient characteristic, fasting plasma β-hydroxybutyrate (BHB) and non-esterified fatty acids (NEFA) at baseline and during 24 months of following a Paleolithic diet (n = 26) or a healthy control diet based on Nordic Nutrition Recommendations (n = 23). Data are presented as mean ± s.e.m. Values within parentheses indicate number (n).
| Paleolithic diet | Control diet | |||||
|---|---|---|---|---|---|---|
| Baseline | 6 months | 24 months | Baseline | 6 months | 24 months | |
| Age (years) | 61 ± 1 | 61 ± 1 | ||||
| Weight, kg | 85.5 ± 2.1 (26) | 76.2 ± 2.1(25)***,### | 77.3 ± 2.3 (26)*,### | 84.9 ± 1.6 (23) | 80.1 ± 1.8 (23)### | 80.1 ± 2.0 (22)### |
| BMI, kg/m2 | 32.5 ± 0.8 (26) | 28.9 ± 0.8 (25)***,### | 29.3 ± 0.8 (26)*,### | 32.1 ± 0.5 (23) | 30.3 ± 0.6 (23)### | 30.4 ± 0.7 (22)### |
| Fat mass, kg | 39.2 ± 1.5 (26) | 31.9 ± 1.5 (26)***,### | 33.8 ± 1.6 (23)*,### | 39.2 ± 1.1 (23) | 35.3 ± 1.4 (23)### | 35.7 ± 1.5 (22)### |
| Fasting plasma BHB† | 3.8 ± 0.7 (25) | 5.8 ± 1.3 (25)*,# | 5.3 ± 0.9 (21) | 3.0 ± 0.4 (22) | 3.4 ± 0.8 (21) | 4.1 ± 1.1 (22) |
| Fasting NEFA (mmol/L) | 0.48 ± 0.04 (26) | 0.42 ± 0.03 (26) | 0.40 ± 0.04 (26) | 0.50 ± 0.03 (23) | 0.45 ± 0.03 (23) | 0.45 ± 0.04 (22) |
*P < 0.05, ***P < 0.001 for the difference between diet groups. #P < 0.05, ###P < 0.001 for the within-group change over time vs baseline. †Values represent relative concentration.
This work is licensed under a